Cancer Res

• 

  Publication Venue For

  • Abstract 95: Uncommitted cells and phenotypic plasticity elucidate the complexity of the epithelial-mesenchymal molecular gradient of pleural mesothelioma.  83:95-95. 2023
  • Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort..  83:386-397. 2023
  • Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer..  83:301-315. 2023
  • Common Germline Risk Variants Impact Somatic Alterations and Clinical Features across Cancers..  83:20-27. 2023
  • The 5-Hydroxymethylcytosine Landscape of Prostate Cancer..  82:3888-3902. 2022
  • Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer..  82:3058-3073. 2022
  • SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy..  82:2748-2760. 2022
  • Abstract CT001: Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells.  82:CT001-CT001. 2022
  • The "Inside" Story on Tumor-Expressed PD-L1..  82:2069-2071. 2022
  • Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers..  82:665-680. 2022
  • Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages..  81:5425-5437. 2021
  • Mechanisms of Therapeutic Antitumor Monoclonal Antibodies..  81:4641-4651. 2021
  • Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle..  81:4618-4627. 2021
  • Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis..  81:3890-3904. 2021
  • Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma..  81:3777-3790. 2021
  • mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK..  81:3174-3186. 2021
  • GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy..  81:2345-2357. 2021
  • Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway..  81:464-475. 2021
  • Dissecting the Functional Significance of DNA Polymerase Mutations in Cancer..  80:5459-5461. 2020
  • The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition..  80:5619-5632. 2020
  • CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade..  80:5063-5075. 2020
  • Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer..  80:4904-4917. 2020
  • Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers..  80:4514-4526. 2020
  • IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils..  80:3088-3100. 2020
  • A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck..  80:2451-2460. 2020
  • Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors..  80:2427-2436. 2020
  • ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming..  80:1669-1680. 2020
  • A New Assay to Measure Intestinal Crypt Survival after Irradiation: Challenges and Opportunities..  80:927-928. 2020
  • An Engineered Tumor-on-a-Chip Device with Breast Cancer-Immune Cell Interactions for Assessing T-cell Recruitment..  80:263-275. 2020
  • Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity..  79:5394-5406. 2019
  • AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells..  79:5034-5047. 2019
  • MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation..  79:3383-3394. 2019
  • Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?.  79:2447-2456. 2019
  • Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma..  79:2065-2071. 2019
  • Deletion of Atm in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung Adenocarcinoma..  79:773-782. 2019
  • Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus..  79:467-481. 2019
  • Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk..  79:505-517. 2019
  • UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling..  78:6462-6472. 2018
  • Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men..  78:6134-6145. 2018
  • Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer..  78:6235-6246. 2018
  • Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer..  78:6146-6158. 2018
  • Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis..  78:5513-5520. 2018
  • A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk..  78:5419-5430. 2018
  • Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting..  78:4997-5010. 2018
  • Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer..  78:4524-4532. 2018
  • Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses..  78:4303-4315. 2018
  • Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors..  78:3672-3687. 2018
  • Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction..  78:3233-3242. 2018
  • MYD88 L265P Mutation in Lymphoid Malignancies..  78:2457-2462. 2018
  • XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype..  78:1726-1738. 2018
  • Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response..  78:853-864. 2018
  • Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities..  78:36-50. 2018
  • Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma..  78:256-264. 2018
  • Distinct Angiogenic Changes during Carcinogenesis Defined by Novel Label-Free Dark-Field Imaging in a Hamster Cheek Pouch Model..  77:7109-7119. 2017
  • Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation..  77:6097-6108. 2017
  • Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors..  77:6240-6252. 2017
  • Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric..  77:6415-6428. 2017
  • Cancer Informatics: New Tools for a Data-Driven Age in Cancer Research..  77:e1-e2. 2017
  • NF1+/- Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response..  77:4486-4497. 2017
  • Hypercholesterolemia Increases Colorectal Cancer Incidence by Reducing Production of NKT and γδ T Cells from Hematopoietic Stem Cells..  77:2351-2362. 2017
  • CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer..  77:1662-1673. 2017
  • Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia..  77:1674-1683. 2017
  • Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach..  76:7078-7088. 2016
  • Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma..  76:6964-6974. 2016
  • Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process..  76:6680-6689. 2016
  • BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer..  76:6320-6330. 2016
  • Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis..  76:6253-6265. 2016
  • Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis..  76:5798-5809. 2016
  • Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations..  76:5103-5114. 2016
  • Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors..  76:5143-5150. 2016
  • Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data..  76:4032-4050. 2016
  • Commentary on "Participation of p53 Protein in the Cellular Response to DNA Damage"..  76:3663-3665. 2016
  • Implications of Increase in Vascular Permeability in Tumors by VEGF: A Commentary on the Pioneering Work of Harold Dvorak..  76:3118-3120. 2016
  • IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors..  76:2561-2572. 2016
  • A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo..  76:2465-2477. 2016
  • Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes..  76:2394-2405. 2016
  • Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas..  76:1892-1903. 2016
  • STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment..  76:999-1008. 2016
  • Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging..  76:769-772. 2016
  • Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer..  76:227-238. 2016
  • Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis..  76:339-346. 2016
  • Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer..  75:5034-5045. 2015
  • A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution..  75:4884-4894. 2015
  • Mitochondrial Superoxide Dismutase Has a Protumorigenic Role in Ovarian Clear Cell Carcinoma..  75:4973-4984. 2015
  • Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS..  75:4527-4537. 2015
  • Mapping the Pathways of Resistance to Targeted Therapies..  75:4247-4251. 2015
  • EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1..  75:3077-3086. 2015
  • Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding..  75:2699-2707. 2015
  • Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle..  75:1356-1365. 2015
  • Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition..  75:1244-1254. 2015
  • Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery..  75:1376-1387. 2015
  • CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy..  75:950-962. 2015
  • Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway..  75:605-614. 2015
  • Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain..  75:554-565. 2015
  • Oncogene pathway activation in mammary tumors dictates FDG-PET uptake..  74:7583-7598. 2014
  • STAT1 drives tumor progression in serous papillary endometrial cancer..  74:6519-6530. 2014
  • Copper signaling axis as a target for prostate cancer therapeutics..  74:5819-5831. 2014
  • Obesity, cholesterol metabolism, and breast cancer pathogenesis..  74:4976-4982. 2014
  • Notch3 pathway alterations in ovarian cancer..  74:3282-3293. 2014
  • Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers..  74:3146-3156. 2014
  • Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1..  74:2171-2181. 2014
  • ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells..  74:1778-1788. 2014
  • Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10..  74:852-861. 2014
  • A reevaluation of CD22 expression in human lung cancer..  74:263-271. 2014
  • The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular development..  74:38-43. 2014
  • A novel EGFR isoform confers increased invasiveness to cancer cells..  73:7056-7067. 2013
  • Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases..  73:6310-6322. 2013
  • Tumor cells upregulate normoxic HIF-1α in response to doxorubicin..  73:6230-6242. 2013
  • Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma..  73:5996-6003. 2013
  • Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL..  73:5029-5039. 2013
  • Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment..  73:3842-3851. 2013
  • Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee..  73:2718-2736. 2013
  • Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma..  73:1374-1385. 2013
  • Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas..  73:496-501. 2013
  • Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer..  73:502-507. 2013
  • Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer..  73:256-264. 2013
  • Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma..  72:6344-6350. 2012
  • Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ..  72:5956-5965. 2012
  • Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein..  72:5912-5920. 2012
  • Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors..  72:5566-5575. 2012
  • Targeting eNOS in pancreatic cancer..  72:4472-4482. 2012
  • Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers codriven by mutant EGFR containing T790M and MET..  72:3302-3311. 2012
  • Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells..  72:1878-1889. 2012
  • Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer..  72:1683-1693. 2012
  • Ovarian cancer risk associated with inherited inflammation-related variants..  72:1064-1069. 2012
  • Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas..  72:1013-1022. 2012
  • Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs..  72:491-502. 2012
  • Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium..  71:7568-7575. 2011
  • Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells..  71:7452-7462. 2011
  • Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer..  71:6738-6748. 2011
  • Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence..  71:6195-6207. 2011
  • Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition..  71:5204-5213. 2011
  • Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines..  71:5075-5080. 2011
  • CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability..  71:4866-4876. 2011
  • HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis..  71:4380-4391. 2011
  • Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations..  71:4172-4182. 2011
  • Quantitative, noninvasive imaging of radiation-induced DNA double-strand breaks in vivo..  71:4130-4137. 2011
  • Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4..  71:3932-3940. 2011
  • LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer..  71:3896-3903. 2011
  • Paradoxical relationship between chromosomal instability and survival outcome in cancer..  71:3447-3452. 2011
  • Invasive prostate carcinoma driven by c-Src and androgen receptor synergy..  71:862-872. 2011
  • CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells..  71:528-537. 2011
  • Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing..  71:29-39. 2011
  • Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration..  70:10182-10191. 2010
  • Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer..  70:9959-9968. 2010
  • WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration..  70:9298-9308. 2010
  • Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl..  70:8066-8076. 2010
  • Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells..  70:7690-7698. 2010
  • Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma..  70:7199-7208. 2010
  • Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity..  70:7209-7220. 2010
  • A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk..  70:6509-6515. 2010
  • The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia..  70:3080-3088. 2010
  • Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation..  70:2932-2941. 2010
  • Definition of a functional single nucleotide polymorphism in the cell migration inhibitory gene MIIP that affects the risk of breast cancer..  70:1024-1032. 2010
  • The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells..  70:1184-1194. 2010
  • OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas..  70:181-191. 2010
  • Mutant metabolic enzymes are at the origin of gliomas..  69:9157-9159. 2009
  • Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress..  69:9105-9111. 2009
  • Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer..  69:7905-7910. 2009
  • MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy..  69:7803-7810. 2009
  • In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells..  69:7329-7337. 2009
  • A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion..  69:6790-6798. 2009
  • CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion..  69:6331-6338. 2009
  • Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer..  69:5820-5828. 2009
  • Sample type bias in the analysis of cancer genomes..  69:5630-5633. 2009
  • Activation of Rap1 promotes prostate cancer metastasis..  69:4962-4968. 2009
  • A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR..  69:3856-3865. 2009
  • Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress..  69:3842-3849. 2009
  • Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo..  69:2919-2926. 2009
  • Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway..  69:2400-2407. 2009
  • Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer..  69:2349-2357. 2009
  • Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis..  69:1517-1526. 2009
  • Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection..  69:1055-1062. 2009
  • Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer..  69:1063-1070. 2009
  • Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis..  69:45-54. 2009
  • Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis..  69:253-261. 2009
  • Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma..  68:10300-10306. 2008
  • Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma..  68:9583-9588. 2008
  • In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells..  68:9892-9899. 2008
  • Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression..  68:9663-9670. 2008
  • Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis..  68:8993-8997. 2008
  • Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer..  68:8805-8812. 2008
  • Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2..  68:8377-8383. 2008
  • Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma..  68:8525-8534. 2008
  • Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity..  68:7684-7691. 2008
  • Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic..  68:7475-7483. 2008
  • The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis..  68:7561-7569. 2008
  • Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation..  68:7466-7474. 2008
  • Chromosome 17q12 variants contribute to risk of early-onset prostate cancer..  68:6492-6495. 2008
  • Targeting cancer stem cells through L1CAM suppresses glioma growth..  68:6043-6048. 2008
  • The pervasive presence of fluctuating oxygenation in tumors..  68:5812-5819. 2008
  • Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo..  68:4990-4997. 2008
  • Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer..  68:4623-4630. 2008
  • Chromosome instability and risk of squamous cell carcinomas of head and neck..  68:4479-4485. 2008
  • Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene..  68:4277-4286. 2008
  • Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12..  68:4045-4049. 2008
  • Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment..  68:3777-3784. 2008
  • Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme..  68:2564-2569. 2008
  • Genetic variation in the one-carbon transfer pathway and ovarian cancer risk..  68:2498-2506. 2008
  • Origins and prevalence of the American Founder Mutation of MSH2..  68:2145-2153. 2008
  • Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors..  68:2436-2446. 2008
  • Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14..  68:1012-1021. 2008
  • Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells..  68:580-588. 2008
  • Circulating levels of inflammatory cytokines and risk of colorectal adenomas..  68:323-328. 2008
  • Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis..  68:162-171. 2008
  • Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis..  67:12026-12033. 2007
  • Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling..  67:11377-11385. 2007
  • Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis..  67:10214-10221. 2007
  • Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation..  67:10528-10537. 2007
  • AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma..  66:8722-8730. 2006
  • Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor..  66:7843-7848. 2006
  • Abstract PR015: Dormant mammary tumors persist long-term despite adaptive immunity by establishing a Treg-dominated niche via DKK3 2023
  • National Cancer Institute Prostate Cancer Genetics Workshop. 2011